AJ Vaccines A/S   Report issue

For profit Phase 4
Founded: Denmark (2017)
Status: No NME R&D (2017)

Organization Overview

First Clinical Trial
2017
NCT03025750
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

AJ Vaccines A/S